ChipMOS TECHNOLOGIES
IMOS
78.60
+0.21
+0.27%
ChipMOS TECHNOLOGIES
US · IMOS
#2580 by market cap
Listed 2010
78.60
+0.21
+0.27%
Live - 5344 symbols - heartbeat 545s ago
· 2026-10-08 07:50
Pre-market
78.96
+0.46%
After-hours
78.60
0.00%
- Market cap
- 2.75B
- P/E (TTM)i
- 38.44
- P/Bi
- 3.53
- EPSi
- 0.48
- Div yieldi
- 0.97%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on IMOS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.32, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.45% YoY
Margins
- Gross margin
- 10.61%
- Operating margin
- 4.77%
- Net margin
- 2.30%
Key ratios & quality
- Enterprise valuei
- 3.36B
- Altman Z-Scorei
- 1.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.48B | 20.34B | 23.01B | 27.40B | 23.52B | 21.36B | 22.70B | 23.93B |
| Gross profit | 3.43B | 3.93B | 5.03B | 7.25B | 4.91B | 3.55B | 2.89B | 2.54B |
| Selling & admin expenses | 538.52M | 554.32M | 585.74M | 677.96M | 666.71M | 633.40M | 607.29M | 611.49M |
| Research & development | 939.27M | 1.01B | 1.02B | 1.14B | 1.16B | 1.09B | 1.16B | 1.08B |
| Operating profit | 1.99B | 2.38B | 3.44B | 5.50B | 3.22B | 1.91B | 1.27B | 1.14B |
| Pretax profit | 1.78B | 3.02B | 2.97B | 6.04B | 4.03B | 2.27B | 1.65B | 590.74M |
| Tax | 456.62M | 513.68M | 594.38M | 1.10B | 588.18M | 300.66M | 207.52M | 40.11M |
| Net profit | 1.33B | 2.51B | 2.38B | 4.94B | 3.44B | 1.97B | 1.44B | 550.64M |
| Basic EPS | 33 | 69 | 65 | 136 | 95 | 54 | 40 | 16 |
| Diluted EPS | 32.60 | 68.00 | 64.60 | 133.00 | 92.60 | 53.60 | 39.20 | 15.40 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.53B | 5.74B | 6.14B | 6.52B | 6.94B | 7.38B |
| Gross profit | 518.39M | 378.80M | 759.70M | 882.01M | 955.47M | 1.33B |
| Selling & admin expenses | 145.64M | -- | -- | -- | 160.24M | -- |
| Research & development | 265.68M | -- | -- | -- | 291.53M | -- |
| Operating profit | 116.03M | 21.20M | 349.50M | 655.99M | 519.68M | 948.00M |
| Pretax profit | 198.11M | -533.10M | 418.00M | 635.68M | 598.15M | 891.70M |
| Tax | 21.81M | -- | -- | -- | 93.26M | -- |
| Net profit | 176.31M | -533.10M | 352.20M | 555.19M | 504.89M | 891.70M |
| Basic EPS | 5 | -15 | 10 | 14 | 14 | 26 |
| Diluted EPS | 4.80 | -15.00 | 10.00 | 14.20 | 14.40 | 25.40 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 11.89B | 11.76B | 12.36B | 14.52B | 18.35B | 25.16B | 23.64B | 25.15B |
| Cash & ST investments | 4.81B | 4.87B | 4.37B | 6.30B | 10.12B | 12.44B | 15.33B | 14.98B |
| Inventory | 1.78B | 1.77B | 2.10B | 3.21B | 3.21B | 2.57B | 2.69B | 3.36B |
| Total assets | 33.13B | 34.31B | 35.08B | 42.52B | 44.94B | 46.16B | 45.38B | 45.35B |
| Total current liabilities | 5.24B | 5.02B | 5.73B | 7.41B | 6.49B | 7.44B | 8.74B | 10.48B |
| Short-term debt | 765.21M | 772.99M | 883.80M | 948.38M | 1.68B | 2.52B | 3.90B | 5.72B |
| Long-term debt | 9.04B | 8.29B | 6.99B | 9.37B | 12.44B | 12.65B | 10.43B | 9.87B |
| Total liabilities | 15,112,545,000.00 | 14,775,302,000.00 | 14,364,975,000.00 | 18,380,369,000.00 | 20,303,685,000.00 | 21,397,287,000.00 | 20,376,534,000.00 | 21,365,309,000.00 |
| Total equity | 18.02B | 19.53B | 20.72B | 24.14B | 24.64B | 24.76B | 25.00B | 23.99B |
| Retained earnings | 3.60B | 4.65B | 5.40B | 8.52B | 8.51B | 8.46B | 8.44B | 7.79B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 23.15B | 23.07B | 25.15B | 24.34B | 25.57B |
| Cash & ST investments | -- | -- | -- | 14.98B | 12.49B | -- |
| Inventory | -- | -- | -- | 3.36B | 4.52B | -- |
| Total assets | -- | 43.52B | 42.95B | 45.35B | 44.83B | 46.96B |
| Total current liabilities | -- | 10.13B | 9.32B | 10.48B | 9.99B | 10.72B |
| Short-term debt | -- | -- | -- | 5.72B | 5.86B | -- |
| Long-term debt | -- | -- | -- | 9.87B | 9.18B | -- |
| Total liabilities | -- | 20,265,100,000.00 | 19,574,400,000.00 | 21,365,309,000.00 | 20,223,938,000.00 | 22,114,100,000.00 |
| Total equity | -- | 23.26B | 23.37B | 23.99B | 24.61B | 24.85B |
| Retained earnings | -- | -- | -- | 7.79B | 8.30B | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.13B | 5.98B | 5.94B | 7.32B | 8.62B | 6.61B | 5.94B | 4.00B |
| Depreciation & amortization | 3.38B | 3.73B | 4.18B | 4.63B | 4.75B | 4.78B | 4.86B | 5.10B |
| Free cash flow | -25.01M | 541.82M | 1.98B | 1.44B | 3.92B | 3.53B | 859.43M | 145.20M |
| Dividends paid | -256.81M | -872.72M | -1.31B | -1.60B | -3.13B | -1.67B | -1.31B | -872.69M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | 0 | 0 | -943.87M |
| Ending cash balance | 4.64B | 4.70B | 4.11B | 5.91B | 9.90B | 12.35B | 15.22B | 14.86B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.05B | -112.74M | 1.17B | 1.89B | 327.71M | 1.20B |
| Depreciation & amortization | 1.31B | -- | -- | -- | 1.25B | -- |
| Free cash flow | -659.95M | 1.60B | 1.17B | -1.96B | -1.06B | 2.59B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -321.71M | -- | -- | -- | 0 | -- |
| Ending cash balance | 13.57B | 13.66B | 12.98B | 14.86B | 12.39B | 12.55B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 7.34 | 13.36 | 11.82 | 22.01 | 14.10 | 7.97 | 5.79 | 2.25 |
| ROA %i | 3.99 | 7.44 | 6.86 | 12.72 | 7.87 | 4.32 | 3.15 | 1.21 |
| ROIC %i | 4.96 | 9.10 | 8.49 | 15.60 | 9.41 | 5.06 | 3.73 | 1.50 |
| 5-year avg ROE %i | 12.95 | 11.63 | 11.70 | 14.16 | 13.73 | 13.85 | 12.34 | 10.42 |
| EBIT margin %i | 10.47 | 15.70 | 13.63 | 22.47 | 17.73 | 11.87 | 8.48 | 3.73 |
| FCF / sales %i | -- | 2.66 | 8.60 | 5.25 | 16.66 | 16.55 | 3.79 | 0.61 |
| Current ratioi | 2.27 | 2.34 | 2.16 | 1.96 | 2.83 | 3.38 | 2.71 | 2.40 |
| Quick ratioi | 1.92 | 1.98 | 1.78 | 1.51 | 2.31 | 2.45 | 2.38 | 2.07 |
| Debt / assetsi | 29.60 | 28.38 | 24.53 | 25.86 | 33.13 | 34.61 | 33.40 | 36.00 |
| LT debt / equityi | 50.17 | 45.89 | 37.28 | 41.62 | 53.59 | 54.36 | 45.01 | 44.22 |
| Interest coveragei | 12.69 | 18.67 | 19.31 | 50.88 | 29.28 | 9.53 | 6.91 | 2.96 |
| Revenue CAGR (3Y) %i | -0.64 | 3.42 | 8.65 | 14.03 | 4.96 | -2.46 | -6.09 | 0.59 |
| Net income CAGR (3Y) %i | -14.62 | 13.69 | -5.25 | 55.00 | 11.10 | -6.13 | -33.69 | -45.70 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 93.36 | 21.31 | -15.77 | -66.66 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | 1.91 | 0.30 | 2.25 | 3.57 | 9.58 |
| ROA %i | -- | 1.02 | 0.17 | 1.21 | 1.96 | 5.09 |
| ROIC %i | -- | 1.91 | 0.30 | 1.50 | 2.36 | 9.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | 6.95 | 4.13 | 3.73 | 5.16 | 10.55 |
| FCF / sales %i | -- | -- | -- | 0.61 | -- | 2.75 |
| Current ratioi | -- | 2.29 | 2.47 | 2.40 | 2.44 | 2.39 |
| Quick ratioi | -- | -- | -- | 2.07 | 1.97 | -- |
| Debt / assetsi | -- | -- | -- | 36.00 | 35.29 | -- |
| LT debt / equityi | -- | -- | -- | 44.22 | 40.49 | -- |
| Interest coveragei | -- | -- | -- | 2.96 | 4.12 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Assembly is the largest reported line at 28.53% of revenue, across 6 reported segments.
- No single line clears half of revenue; Services for Display panel driver semiconductor assembly and testing (LCDD) is next at 24.53%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Assembly28.53%
Services for Display panel driver semiconductor assembly and testing (LCDD)24.53%
Testing23.72%
Bumping23.22%
Others0.24%
Region
Republic of China (Taiwan) (ROC)86.85%
People’s Republic of China (PRC)5.98%
Japan5.13%
Others2.05%
Quote time 2026-10-08 07:50:08 · For reference only, not investment advice and not tailored to your situation.